Dorman Susan E, Guide Shireen V, Conville Patricia S, DeCarlo Ellen S, Malech Harry L, Gallin John I, Witebsky Frank G, Holland Steven M
Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Clin Infect Dis. 2002 Aug 15;35(4):390-4. doi: 10.1086/341416. Epub 2002 Jul 23.
To determine the clinical characteristics and outcome of Nocardia infection in patients with chronic granulomatous disease (CGD), we reviewed data on 28 episodes of Nocardia infection in 23 patients with CGD. All episodes involved pulmonary infection. The frequency of disseminated nocardiosis was 25% for the case series overall, but it was 56% among episodes in patients receiving neither interferon-gamma (IFN-gamma) nor sulfonamide prophylaxis. Patients receiving prophylaxis with IFN-gamma and/or a sulfonamide were significantly less likely to have disseminated nocardiosis than were patients not receiving these medications, and no patient receiving both medications developed disseminated nocardiosis. One-third of the patients had concomitant fungal infections, and 2 patients had concomitant Legionella infections. The majority of patients were successfully treated with a sulfonamide-containing regimen, even though some patients had developed Nocardia infection while receiving sulfonamide prophylaxis. Nocardia infections in patients with CGD are not usually fatal if treated properly, and prophylaxis with IFN-gamma and a sulfonamide may protect against dissemination.
为了确定慢性肉芽肿病(CGD)患者诺卡菌感染的临床特征及转归,我们回顾了23例CGD患者28次诺卡菌感染的数据。所有感染均累及肺部。在整个病例系列中,播散性诺卡菌病的发生率为25%,但在既未接受γ干扰素(IFN-γ)也未接受磺胺类药物预防的患者中,该发生率为56%。与未接受这些药物治疗的患者相比,接受IFN-γ和/或磺胺类药物预防的患者发生播散性诺卡菌病的可能性显著降低,且同时接受这两种药物治疗的患者均未发生播散性诺卡菌病。三分之一的患者合并真菌感染,2例患者合并军团菌感染。尽管有些患者在接受磺胺类药物预防时发生了诺卡菌感染,但大多数患者通过含磺胺类药物的方案成功治愈。CGD患者的诺卡菌感染若得到恰当治疗通常不会致命,且使用IFN-γ和磺胺类药物进行预防可能防止感染播散。